Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|32|5764-5774

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.32, 2013-10, pp. : 5764-5774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Traditional Drug Targets: High Risk, High Reward

By  

Current Gene Therapy, Vol. 3, Iss. 5, 2003-10 ,pp. : 395-404

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemical Markers of Cardiovascular Damage from Tobacco Smoke

By  

Current Pharmaceutical Design, Vol. 11, Iss. 17, 2005-07 ,pp. : 2199-2208

Bentham Science Publishers

Access to resources Recommend Favorite

Liver Enzymes: Potential Cardiovascular Risk Markers?

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3632-3643

Bentham Science Publishers

Access to resources Recommend Favorite

The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 908-921

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Tests: Use & Limits of Biochemical Markers - Therapeutic Measurements of ADMA Involved in Cardiovascular Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 17, 2005-07 ,pp. : 2177-2185

Bentham Science Publishers

Access to resources Recommend Favorite